Relive® Sicca - Dry eye - Nanoemulsion eye drops - MD
Product Description
Laboratorios Salvat, S.A.
-
ES -
2016On CPHI since
-
4Certificates
-
250 - 499Employees
Company types
Primary activities
.jpg)
Categories
Specifications
Laboratorios Salvat, S.A.
-
ES
-
2016On CPHI since
-
4Certificates
-
250 - 499Employees
Company types
Primary activities
More Products from Laboratorios Salvat, S.A. (21)
-
Product Ophthalmic CDMO Services
Salvat offers the best services and solutions, drawing on a long history of expertise in developing and manufacturing successful medications.
Tailored solutions to customer needs through our Ophthalmic platform: • • Customized solutions using Salvat's technology: suspensions, solutions, micellar,... -
Product Contract Development & Manufacturing Services (CDMO)
With 70 years of experience in developing and manufacturing pharmaceutical products for diverse markets, we excel in Operational Excellence, Flexibility, and Adaptability.
Salvat offers integrated CDMO services with state-of-the-art manufacturing facilities in Barcelona, Madrid, and Miami, equip... -
Product Blow-Fill-Seal Technology (BFS) Single-dose vials CDMO
Salvat specializes in developing and manufacturing sterile liquid pharmaceutical products in single-dose vials using Blow-Fill-Seal (BFS) technology.
Advantages of using Blow-Fill-Seal technology in your products:
• • Innovative format, providing differentiation for your produ... -
Product Bimeox® 0.3mg/ml - Glaucoma (Preservative-free) - Rx
Bimeox® Bimatoprost 0.3 mg/ml, a well-known prostaglandin analogue eye drop, preservative-free, presented in single-dose vials using our Blow-Fill-Seal Technology.
• Innovative format in single-dose vials • Preservative-free for better tolerability • Sterile until ope... -
Product Tanolux® 50 ug/ml - Glaucoma - Rx
Tanolux® Latanoprost 50 ug/ml, a well-known prostaglandin analogue eye drop, presented in single-dose vials using our Blow-Fill-Seal Technology.
• Innovative format in single-dose vials • No cold chain required, easy to store & carry • Vey low solvents concentration vs ... -
Product Tebarat 0.5 mg/ml - Allergic conjunctivitis - single-dose vials eye drops - Rx
Tebarat 0.5 mg/ml eye drops are indicated for the treatment and prevention of allergic conjunctivitis. Treatment and prevention of seasonal allergic conjunctivitis symptoms in adults and children aged 4 years and over.Treatment of non-seasonal (perennial) allergic conjunctivitis symptoms in adults and chil... -
Product Relive® Total Care - Lubrication + UV protection eye drops - MD
Regenerate, protect against UV radiation, and lubricate. Eye tears, specially designed for after surgery.
• 20 unit dose vials of 0,4 ml • Preservative free • With Actinoquinol 0,3%, Cyanocobalamin 0,05%, PVPK 30 1,5% -
Product Relive® - Day & Night eye drops - MD
RELIVE® DRY EYE - 8 Hours of Dry Eye Relief
RELIVE® NIGHT - 12 Hours of Long-lasting Dry Eye Relief • Preservative-Free • Phosphate-Free • Single-dose vials, very Convenient format -
Product Cetraxal® Plus 3mg/ml + 0.25 mg/ml - AOE & AOMT - Otic solution Rx
Unique combination "ciprofloxacin 3 mg + Fluocinolone 0.25 mg" topical solution
Indication: Acute otitis externa and acute otitis media with perforated eardrums in adults and pediatric patients.
Dosage regimen: B.I.D x 7 days
Presentation of multi-dose 10 ml and unit dose vials (14... -
Product Ekzem® 0.25 mg/ml - Otic eczema - single-dose vials - otic solution Rx
Fluocinolone acetonide, topical solution. Ekzem is indicated for the treatment of otic eczema in adults. Demonstrated efficacy and safety in clinical studies
Available in unit dose vials of 0.4 ml each. (30 vials x box) -
Product Cristalmina® - Antiseptic - OTC
Chlorhexidine digluconate 1% Cristalmina®, offers a quick action and long-lasting effect.
Cristalmina®, the antiseptic leader in the Spanish market, is the most complete, for the whole family
Indication: Minor skin wounds and burns, even for the umbilical cord in newborns. -
Product Cetraxal® Otico 2mg/ml - AOE - Otic solution Rx
Ciprofloxacin 3 mg, topical solution.
Indication: AOE
Dosage: B.I.D x 7 days.
Presentation: Available in multidose 10ml and unit dose vials (15 vials).
Laboratorios Salvat, S.A. resources (2)
-
News Laboratorios Salvat inicia un estudio pediátrico pionero en Europa con su fármaco innovador SVT-15473, para el tratamiento de la inflamación y dolor tras la cirugía ocular
- Los ensayos clínicos fase III realizados en adultos confirman la eficacia y el excelente perfil de seguridad de SVT-15473 clobetasol oftálmico, formulado con IMPACT-SVT® tecnología patentada de nanoemulsiones, para el tratamiento de la inflamación y el dolor después de una cirugía ocular.
- Es el primer estudio clínico que se realiza en paciente pediátrico con un corticoide tópico oftálmico en toda Europa.
- Con el nuevo estudio que se inicia ahora y que se llevará a cabo en seis hospitales españoles se espera demostrar también su seguridad en pacientes pediátricos de 0 a 3 años.
- Con este proyecto, que ha supuesto una inversión global de más de 20 millones de euros, Laboratorios Salvat da un paso más en su estrategia de afianzarse como un actor clave en el área de oftalmología a nivel internacional.
-
Video SVT-15473 + IMPACT-SVT® Nanoemulsion technology
Salvat has developed IMPACT-SVT®, a patented nanoemulsion drug delivery technology that improves drug mucus penetration and bio-adhesion, providing excellent ocular comfort.
IMPACT-SVT® made it possible to develop SVT-15473, using the strongest corticosteroid in the global market.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance